These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 30667502)

  • 21. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Asghari S; Asghari-Jafarabadi M; Somi MH; Ghavami SM; Rafraf M
    J Am Coll Nutr; 2018; 37(3):223-233. PubMed ID: 29313746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial.
    Jeong JY; Sohn JH; Baek YH; Cho YK; Kim Y; Kim H
    World J Gastroenterol; 2017 Aug; 23(32):5977-5985. PubMed ID: 28932090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.
    Schwimmer JB; Lavine JE; Wilson LA; Neuschwander-Tetri BA; Xanthakos SA; Kohli R; Barlow SE; Vos MB; Karpen SJ; Molleston JP; Whitington PF; Rosenthal P; Jain AK; Murray KF; Brunt EM; Kleiner DE; Van Natta ML; Clark JM; Tonascia J; Doo E;
    Gastroenterology; 2016 Dec; 151(6):1141-1154.e9. PubMed ID: 27569726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.
    Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Azadbakht L
    Nutrition; 2014; 30(7-8):814-21. PubMed ID: 24984998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
    Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
    Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Intermittent Compared With Continuous Energy Restricted Diet on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Noninferiority Trial.
    Carter S; Clifton PM; Keogh JB
    JAMA Netw Open; 2018 Jul; 1(3):e180756. PubMed ID: 30646030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
    Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
    J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study.
    Pfirrmann D; Huber Y; Schattenberg JM; Simon P
    J Med Internet Res; 2019 Jan; 21(1):e11250. PubMed ID: 30602434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial.
    Campos V; Despland C; Brandejsky V; Kreis R; Schneiter P; Boesch C; Tappy L
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial.
    Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
    Trials; 2018 Nov; 19(1):634. PubMed ID: 30445988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial.
    Goss AM; Dowla S; Pendergrass M; Ashraf A; Bolding M; Morrison S; Amerson A; Soleymani T; Gower B
    Pediatr Obes; 2020 Jul; 15(7):e12630. PubMed ID: 32128995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Soy Milk on Metabolic Status of Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Eslami O; Shidfar F; Maleki Z; Jazayeri S; Hosseini AF; Agah S; Ardiyani F
    J Am Coll Nutr; 2019 Jan; 38(1):51-58. PubMed ID: 30028245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial.
    Properzi C; O'Sullivan TA; Sherriff JL; Ching HL; Jeffrey GP; Buckley RF; Tibballs J; MacQuillan GC; Garas G; Adams LA
    Hepatology; 2018 Nov; 68(5):1741-1754. PubMed ID: 29729189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease.
    Johari MI; Yusoff K; Haron J; Nadarajan C; Ibrahim KN; Wong MS; Hafidz MIA; Chua BE; Hamid N; Arifin WN; Ma ZF; Lee YY
    Sci Rep; 2019 Aug; 9(1):11232. PubMed ID: 31375753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children.
    Ramon-Krauel M; Salsberg SL; Ebbeling CB; Voss SD; Mulkern RV; Apura MM; Cooke EA; Sarao K; Jonas MM; Ludwig DS
    Child Obes; 2013 Jun; 9(3):252-60. PubMed ID: 23705885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
    Huang Y; Fu JF; Shi HB; Liu LR
    Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Bakhshimoghaddam F; Shateri K; Sina M; Hashemian M; Alizadeh M
    J Nutr; 2018 Aug; 148(8):1276-1284. PubMed ID: 29931231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.